Finch: Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

Finch Therapeutics Group, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 0.107 million compared to USD 0.861 million a year ago. Net loss was USD 74.75 million compared to USD 114.65 million a year ago. Basic loss per share from continuing operations was USD 46.59 compared to USD 72.12 a year ago. Diluted loss per share from continuing operations was USD 46.59 compared to USD 72.12 a year ago.